These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30843756)

  • 21. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
    Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
    PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    Johnson TW; Wu Y; Nathoo N; Rogers JA; Wee Yong V; Dunn JF
    PLoS One; 2016; 11(12):e0167196. PubMed ID: 27907119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocytes lure CXCR2-expressing CD4
    Khaw YM; Tierney A; Cunningham C; Soto-Díaz K; Kang E; Steelman AJ; Inoue M
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33597297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
    Ciampi E; Pareto D; Sastre-Garriga J; Vidal-Jordana A; Tur C; Río J; Tintoré M; Auger C; Rovira A; Montalban X
    Mult Scler; 2017 Apr; 23(4):556-566. PubMed ID: 27354019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis.
    Paquin MÊ; El Mendili MM; Gros C; Dupont SM; Cohen-Adad J; Pradat PF
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):184-192. PubMed ID: 29122760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.
    Cahill LS; Zhang MA; Ramaglia V; Whetstone H; Sabbagh MP; Yi TJ; Woo L; Przybycien TS; Moshkova M; Zhao FL; Rojas OL; Gomes J; Kuerten S; Gommerman JL; Sled JG; Dunn SE
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22710-22720. PubMed ID: 31641069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
    Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
    J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis.
    Devine MS; Pannek K; Coulthard A; McCombe PA; Rose SE; Henderson RD
    Neuroimage Clin; 2015; 7():782-7. PubMed ID: 25844330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
    Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.
    Kim JH; Budde MD; Liang HF; Klein RS; Russell JH; Cross AH; Song SK
    Neurobiol Dis; 2006 Mar; 21(3):626-32. PubMed ID: 16298135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gray Matter Volume Changes over the Whole Brain in the Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis: a Voxel-based Morphometry Study.
    Chen ZY; Liu MQ; Ma L
    Chin Med Sci J; 2018 Mar; 33(1):20-28. PubMed ID: 29620511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of spinal cord lesions in a primate model of multiple sclerosis.
    Lefeuvre JA; Guy JR; Luciano NJ; Ha SK; Leibovitch E; Santin MD; Silva AC; Jacobson S; Lehéricy S; Reich DS; Sati P
    Mult Scler; 2020 Mar; 26(3):284-293. PubMed ID: 30730246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.